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Background: Increasing evidence indicates that dysregulation of microRNAs is involved in tumor progression and
development. The aim of this study was to investigate the expression of microRNA-24 (miR-24) and its function in
laryngeal squamous cell carcinoma (LSCC).
Methods: Quantitative RT-PCR (qRT-PCR) was used to detect miR-24 expression in LSCC cell lines and tissue samples.
MTT, colony formation, and flow cytometry was performed to analyze the effects of miR-24 expression on growth,
apoptosis, and radiosensitivity of LSCC cells. Dual-luciferase reporter assays were performed to examine regulation of
putative miR-24 targets. Expression of X-linked inhibitor of apoptosis protein (XIAP) mRNA and protein, cleaved or total
caspase-3, and cleaved or total PARP protein were detected by qRT-PCR and western blotting assays, respectively.
Results: miR-24 expression levels in LSCC cell lines or tissue were significantly lower than in a normal human
keratinocyte cell line or adjacent normal tissues. Functional analyses indicated that re-expression of miR-24 inhibits
growth, reduces colony formation, and enhances apoptosis in LSCC cells. In addition, miR-24 upregulation increases
LSCC sensitivity to irradiation by enhancing irradiation-induced apoptosis, and luciferase activity indicated that miR-24
binds to the 3′-untranslated region (3′-UTR) of XIAP mRNA. Upregulation of miR-24 inhibits XIAP protein expression in
LSCC cells, and silencing of XIAP mimics the effects of miR-24 upregulation on LSCC cells. In addition, XIAP mRNA
expression significantly increases in LSCC tissues and is inversely correlated with miR-24 expression.
Conclusions: Our data suggest that miR-24 inhibits growth, increases apoptosis, and enhances radiosensitivity in LSCC
cells by targeting XIAP. Therefore, miR-24 may be a potential molecular target for the treatment of human LSCC.
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Laryngeal squamous cell carcinoma (LSCC), the most
common cancer of the upper digestive tract, accounts
for approximately 14 % of head and neck squamous cell
carcinoma (HNSCC) [1]. Recent advances in the multi-
disciplinary management of the early stages of the* Correspondence: cuipc_xian@163.com
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creativecommons.org/publicdomain/zero/1.0/disease include surgical extirpation or larynx-
preservation protocols using chemoradiotherapy, but a
substantial proportion of patients with localized or lo-
cally advanced disease will eventually relapse and die [2].
Laryngeal carcinogenesis is a complex multistep process
involving genetic dysregulation of proto-oncogenes and
tumor suppressor genes [3]. Thus, it is imperative to
understand the molecular mechanisms that underlie
LSCC development, which may be helpful in identifying
novel therapeutic targets.distributed under the terms of the Creative Commons Attribution License
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RNAs, 17–25 nucleotides long, that associate with 3′-un-
translated regions (3′-UTR) of specific target messenger
RNAs (mRNAs), targeting them for degradation or transla-
tional inhibition [4, 5]. Increasing evidence demonstrates
that dysregulated miRNAs play critical roles in many bio-
logical processes, including growth, apoptosis, development,
and tumorigenesis [6, 7]. Recently, the role of miRNAs in
LSCC development has been the subject of several reports.
Analysis of DNA microarray-based miRNA expression pro-
files derived from formalin-fixed paraffin-embedded (FFPE)
tissue blocks of larynx LSCC, Li et al. observed differentially
expressed miRNAs that may serve as potential molecular
biomarkers for predicting metastatic development in LSCC
[8]. By detecting these LSCC-specific miRNAs in plasma,
Ayaz et al. identified differential expression of miRNAs in
LSCC patient plasma, which may be potential early markers
[9]. In addition, identification of miRNAs and mRNAs asso-
ciated with multidrug resistance of human laryngeal cancer,
suggest that miRNAs may be potential biomarkers for che-
mosensitivity prediction and drug resistance targets in
LSCC [10]. These studies suggest that dysregulation of miR-
NAs may play important roles in LSCC progression and de-
velopment. MiR-24 is an abundant miRNA encoded by the
corresponding gene that maps to human chromosome
9q22 and 19p13 regions, which is well conserved between
species and is expressed in normal tissues such as adipose,
mammary gland, kidney, and differentiated skeletal muscle
[11]. It has been reported that miR-24 functions as a tumor
suppressor in a variety of human cancers, including tongue
squamous cell carcinoma, osteosarcoma, bladder cancer,
and gastric cancer [12–15]. However, the role of miR-24 in
LSCC development and its possible molecular mechanisms
are largely unclear and remain to be further elucidated.Fig. 1 qRT-PCR of miR-24 expression in LSCC cells and tissue samples. a qRT-PC
b qRT-PCR detection of miR-24 expression in 15 paired LSCC and adjacent norm
least in triplicate. Corresponding P values determined by t-tests are indicated. T:In the present study, we show that miR-24 is downregu-
lated in LSCC cell lines and tissue. Additional experiments
demonstrate that re-expression of miR-24 inhibits growth,
enhances apoptosis, and reverses chemoresistance in
LSCC cells by directly targeting XIAP. These results sug-
gest that targeting miR-24 may be a potential strategy for
treating LSCC.
Results
MiR-24 expression is downregulated in LSCC cells and tissues
Our qRT-PCR results indicate that miR-24 expression in
Hep-2 and AMC-HN-8 was lower than that in HaCaT (P <
0.01, Fig. 1a). We also observed that miR-24 expression was
significantly lower in LSCC tissues compared with that in
the adjacent normal tissues (P < 0.01; Fig. 1b). These results
indicate that downregulation of miR-24 may play an im-
portant role in LSCC development.
Re-expression of miR-24 inhibits growth and enhances
apoptosis in LSCC cells
To determine the effects of miR-24 expression on LSCC
cells, pGCMV/miR-224 or pGCMV/miR-NC was stably
transfected into Hep-2 and AMC-HN-8, and qRT-PCR
used to confirm upregulation of miR-24 (Fig. 2a). The
effects of miR-24 expression on LSCC growth were then
examined by MTT and colony formation assays, indicat-
ing reduced growth (Fig. 2b). Similarly, colony formation
capacity in Hep-2/miR-24 and AMC-HN-8/miR-24 cells
was significantly reduced compared to controls (Fig. 2c).
Flow cytometric analysis showed that miR-24 re-expression
enhanced apoptosis in LSCC cells. Furthermore, upregula-
tion of miR-24 increased expression levels of cleaved
caspase-3 (c-caspase-3), cleaved PARP (c-PARP), and de-
creased expression levels of total caspase-3 and PARPR detection of miR-24 expression in Hep-2 and AMC-HN-8 and HaCaT cells.
al tissues. U6 was used as an internal control. Each assay was performed at
LSCC tissues; N: adjacent normal tissues. **P< 0.01 vs control
Fig. 2 Effects of miR-24 expression on growth, colony formation, and apoptosis in LSCC. a qRT-PCR of miR-24 expression in mock or stably transfected
Hep-2 and AMC-HN-8 cells. U6 was used as an internal control. b MTT analysis of Hep-2 and AMC-HN-8 growth following stable transfection with pGCMV/
miR-NC or pGVMV/miR-24, respectively. c Colony formation assay was performed as described in Methods. d Flow cytometric analysis of apoptosis in Hep-2
and AMC-HN-8 stably transfected with pGCMV/miR-NC or pGVMV/miR-24, respectively. eWestern blot detection of c-caspase-3, total caspase-3, c-PARP, and
total PARP in the stably transfected Hep-2 and AMC-HN-8 cells. GAPDH was used as an internal control. Each experiment was performed at least in triplicate.
*P< 0.05, **P< 0.01 vs control
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hibit growth of LSCC cells by inducing caspase-3-
dependent apoptosis.
Re-expression of miR-24 increases radiosensitivity in LSCC
cells by enhancing irradiation-induced apoptosis
We sought to further examine the effects of miR-24 expres-
sion on radiosensitivity of LSCC. When combined with
various doses of irradiation (0.0, 2.0, 4.0, 6.0 or 8.0 Gy), up-
regulation of miR-24 decreased growth of LSCC cells
(Fig. 3a). Similarly, when combined with irradiation
(6.0Gy), colony formation of Hep-2/miR-24 or AMC-HN-
8/miR-24 cells was reduced in comparison with Hep-2/
miR-NC or AMC-HN-8/miR-NC cells (Fig. 3b). Next, we
analyzed the effects of miR-24 expression on apoptosis of
LSCC cells following irradiation and found that miR-24 re-
expression increased irradiation-induced apoptosis of LSCC
cells (Fig. 3c). Upregulation of miR-24 increased expression
of c-caspase-3 and c-PARP proteins in LSCC cells induced
by irradiation treatment (Fig. 3d). Together, these data sug-
gest that upregulation of miR-24 enhances LSCC irradi-
ation sensitivity by increasing irradiation-induced apoptosis.XIAP as a direct target of miR-24 in LSCC cells
To explore how miR-24 affects malignant development of
LSCC, we searched for potential regulatory targets of miR-
24 using three prediction tools (miRanda, PicTar, and Tar-
getScan), and identified a putative miR-24-binding site at
positions 2301–2308 (CUGAGCCA) in the 3′-UTR of
XIAP mRNA. To test directly whether XIAP is a target of
miR-24, we constructed a luciferase reporter (pLUC/XIAP/
3′-UTR-wt) in which the XIAP/3′-UTR nucleotides com-
plementary to miR-24 (nt 2301–2308) were inserted into
the pLUC vector. We also generated a mutant reporter
(pLUC/XIAP/3′-UTR-mut), in which the first six nucleo-
tides in the miR-24 seed region complementary sites were
mutated (Fig. 4a). We then co-transfected appropriate plas-
mids with either the negative control miR-NC or miR-24
mimics into Hep-2 cells, and measured luciferase activity.
Luciferase activity indicated that miR-24 inhibited signal
compared with the miR-NC negative control (Fig. 4b), but
had no effect on the activity of reporter vector containing
the 3′-UTR of XIAP with six point mutations in the miR-
24-binding site, suggesting that miR-24 interacts directly
with the 3′-UTR of XIAP mRNA. Western blot results
Fig. 3 Effect of miR-24 expression on radiosensitivity of LSCC cells. a Radiosensitization by expression of miR-24 was evaluated based on clonogenic cell
survival assays. Stably transfected Hep-2 and AMC-HN-8 cells were exposed to various doses of radiation prior to plating. b Colony formation assay was
performed as described in Methods. c Flow cytometric detection of apoptosis in stably transfected Hep-2 and AMC-HN-8 cells with or without irradiation
(6.0Gy). dWestern blot detection of c-caspase-3, total caspase-3, cleaved c-PARP, and total PARP proteins in the stably transfected Hep-2 and AMC-HN-8
cells with or without irradiation (6.0Gy). GAPDH was used as an internal control. Each experiment was performed at least in triplicate. *P< 0.05, **P< 0.01
vs control
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24 (or Hep-2/miR-NC) and AMC-HN-8/miR-24 (AMC-
HN-8/miR-NC) cells, as miR-24 decreased expression of
XIAP protein in LSCC cells (Fig. 4c). Collectively, these re-
sults indicate that XIAP may be a direct target of miR-24 in
LSCC.
Silencing of XIAP inhibits growth, increases apoptosis,
and enhances radiosensitivity in LSCC cells
To validate that miR-24-mediated effects in LSCC cells
resulted from targeting XIAP, pSil/shXIAP or pSil/
shcontrol was stably transfected into Hep-2 (Hep-2/
shXIAP or Hep-2/shcontrol) and AMC-HN-8 (AMC-
HN-8/shXIAP or AMC-HN-8/shcontrol) cells. Western
blot confirmed the decreased expression of XIAP protein
in Hep-2/shXIAP or AMC-HN-8/shXIAP cells com-
pared with mock Hep-2 or AMC-HN-8, and Hep-2/
shcontrol or AMC-HN-8/sh controls (Fig. 5a). MTT and
colony formation assays revealed that siRNA-mediated
XIAP downregulation decreases growth and colony for-
mation in LSCC cells (Fig. 5b, c). Flow cytometric ana-
lysis further indicated that silencing of XIAP increases
caspase-3-dependent apoptosis in LSCC cells (Fig. 5d, e).
Furthermore, silencing of XIAP increased the sensitivityof LSCC cells to irradiation by enhancing irradiation-
induced caspase-3-dependent apoptosis (Fig. 6a-c).
Therefore, silencing of XIAP mimics the effects of miR-
24 upregulation on LSCC cells.
XIAP is upregulated in LSCC tissues and is inversely
correlated with miR-24 expression
We further examined expression of XIAP mRNA in
HaCaT and Hep-2 and AMC-HN-8 cells by qRT-PCR,
and found that the expression of XIAP mRNA in HaCaT
cell line was lower than that in the LSCC cell lines
(Fig. 7a). In addition, expression of XIAP mRNA in 15
paired LSCC and adjacent normal tissues showed that
XIAP mRNA in LSCC tissues was elevated (P < 0.001;
Fig. 7b). We then observed that expression level of XIAP
mRNA expression levels inversely correlated with the
expression level of miR-24 in LSCC tissues (Pearson’s
correlation, r = −0.508; P < 0.001; Fig. 7c). Therefore, the
increased XIAP mRNA expression in LSCC tissues cor-
relates with low-level miR-24 expression.
Discussion
In the present study, we showed that miR-24 is down-
regulated in LSCC cell lines and tissues. Re-expression
Fig. 4 miR-24 binds to the 3′-UTR of XIAP mRNA. a A human XIAP/3′-UTR fragment containing wild-type or mutant miR-24-binding sequence was
cloned downstream of the luciferase reporter gene in pLUC-luc. b pLUC-luc vector contains XIAP/3′-UTR-wt or XIAP/3′-UTR-mut and pGCMV/miR-24
or pGCMV/miR-NC were co-transfected into Hep-2 cells, and cell lysates prepared at 48 h for measuring luciferase activity, which was normalized to
Renilla luciferase activity. c Western blot detection of XIAP protein expression in the stably transfected Hep-2 and AMC-HN-8 cells. GAPDH was used as
an internal control. Each experiment was performed at least in triplicate. *P < 0.05, **P < 0.01 vs control
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creased radiosensitivity in LSCC cells. Furthermore,
XIAP, a member of the inhibitor of apoptosis family of
proteins, was identified as a functional and direct target
of miR-24. To the best of our knowledge, this is the first
report to elucidate a role for miR-24 in LSCC, suggest-
ing that reduced miR-24 plays a critical role in LSCC
progression by inducing XIAP expression.
miRNAs, which are typically 18–22 nucleotides long, evo-
lutionarily conserved single-stranded RNA molecules, regu-
late target genes by binding to complementary sequences in
the 3′-UTR and play a role in many human physiological
and pathological processes, including cancer [16, 17]. Re-
cently, correlation of dysregulated miRNAs with LSCC has
been reported. Using microarrays, Cao et al. identified 29
differentially expressed miRNAs between LSCC and adja-
cent normal tissues. They observed upregulation of miR-21,
miR-93, miR-205, and miR-708, and downregulation of
miR-125b and miR-145 [18]. In addition, through analysis of
LSCC patient plasma miRNA, Ayaz et al. reported upregu-
lated of 17 miRNAs whereas nine were downregulated. Im-
portantly, five of these (miR-331-3p, 603, 1303, 660-5p, and
212-3p) are LSCC specific, suggesting that LSCC-specific
plasma miRNAs might serve as novel noninvasive LSCCbiomarkers [9]. In addition, miRNAs are correlated with
growth, invasion, and metastasis of LSCC. For example,
Zhao et al. showed that overexpression of miR-155 pro-
motes proliferation and invasion of human LSCC by target-
ing SOCS1 and STAT3 [19]. Zhang et al. reported that
down-regulation of miR-206 promotes proliferation and
invasion of laryngeal cancer via VEGF expression [20]. Fur-
thermore, Tian et al. also showed that miR-203 is downregu-
lated in LSCC and suppresses proliferation and induces
tumor apoptosis [21]. Additional dysregulated miRNAs con-
tribute to LSCC progression, such as miR-93, miR-27a, and
miR-375 [22–24]. These reports suggest that targeting dys-
regulated miRNAs might be a potential strategy for the
treatment of human LSCC. Recently, miR-24 was shown to
be downregulated in nasopharyngeal carcinoma (NPC) and
that is inhibits NPC cell growth, promotes apoptosis, and
suppresses the growth of NPC xenografts [25]. However,
miR-24 expression and its effects on LSCC are unclear.
Here, we show that miR-24 expression in LSCC cell lines
was significantly lower than that in a human keratinocyte
cell line. In addition, miR-24 expression in LSCC tissues was
downregulated in comparison with that in adjacent normal
tissues. Functional analyses demonstrated that re-expression
of miR-24 could inhibit growth, reduce colony formation,
Fig. 5 Effects of XIAP knockdown on growth, colony formation, and apoptosis in LSCC cells. a Western blot of XIAP protein expression in Hep-2
and AMC-HN-8 cells stably transfected with pSil/shXIAP or pSil/shcontrol, respectively. GAPDH was used as an internal control. b MTT analysis of
growth in Hep-2 and AMC-HN-8 cells stably transfected with pSil/shXIAP or pSil/shcontrol, respectively. c Colony formation assay was performed
as described in Methods. d Flow cytometric detection of apoptosis in Hep-2 and AMC-HN-8 cells stably transfected with pSil/shcontrol or pSil/
shXIAP, respectively. e Western blot detection of c-caspase-3, total caspase-3, c-PARP, and total PARP proteins in the stably transfected Hep-2 and
AMC-HN-8. GAPDH was used as an internal control. Each experiment was performed at least in triplicate. *P < 0.05, **P < 0.01 vs control
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Radiotherapy is a crucial treatment in the management of
LSCC, but little tumor-controlling efficacy in some cases is
achieved because of inherent radioresistance. Therefore, a
better understanding of molecular mechanisms in LSCC
radioresistance may help identify a novel molecular target
for radiosensitization of LSCC. Here, we investigated the ef-
fects of miR-24 expression on radiosensitivity of LSCC,
with the results suggesting that miR-24 re-expression in-
creased the sensitivity of LSCC to irradiation by enhancing
irradiation-induced apoptosis. Thus, restoration of miR-24
may be a better method for reversing radioresistance in
LSCC.
miRNAs exert their function in a dynamic and context-
dependent manner by targeting diverse downstream target
genes. Thus, identification of target genes may elucidate
miR-24 function and the molecular mechanisms by which
it mediates LSCC progression. XIAP was identified as adirect target mRNA of miR-24 by bioinformatics analysis.
Previously, Xie et al. reported that miR-24 regulates XIAP
to reduce the apoptosis threshold in cancer cells [26]. How-
ever, whether miR-24 targets XIAP to affect LSCC is poorly
understood. Human XIAP, which belongs to the inhibitor of
apoptosis (IAP) family, is an inhibitor of apoptotic cell death
that protects cells by caspase-dependent and independent
mechanisms [27]. This protein is overexpressed in many
human cancers, which may lead to formation of malignant
phenotypes, such as growth, apoptosis, and chemo and
radioresistance. For example, Zhang et al. reported that
transfer of siRNA against XIAP induces apoptosis and
reduces tumor cell growth in human breast cancer in vitro
and in vivo [28]. Shrikhande et al. showed that silencing
XIAP decreases gemcitabine resistance of pancreatic
cancer cells [29]. In LSCC, Wang et al. showed that
RNA interference-mediated downregulation of XIAP
expression inhibits proliferation and induces apoptosis
Fig. 6 Effect of XIAP knockdown on LSCC radiosensitivity. a Radiosensitization by expression of XIAP was based on clonogenic cell survival assays.
Stably transfected Hep-2 and AMC-HN-8 were exposed to various doses of radiation prior to plating for clonogenic cell survival. b Flow cytometry
of apoptosis in stably transfected Hep-2 and AMC-HN-8 with (6.0Gy) or without irradiation. c Western blot of c-caspase-3, total caspase-3, cleaved
c-PARP, and total PARP in stably transfected Hep-2 and AMC-HN-8 with or without irradiation (6.0Gy). GAPDH was used as an internal control.
Each experiment was performed at least in triplicate. *P < 0.05, **P < 0.01 vs control
Fig. 7 XIAP expression is upregulated in LSCC cells and tissues and inversely correlated with miR-24 expression. a qRT-PCR detection of XIAP mRNA
expression in Hep-2 and AMC-HN-8, and HaCaT cells. GAPDH was used as an internal control. b qRT-PCR detection of XIAP mRNA expression in 15 paired
LSCC tissues and adjacent normal tissues. GAPDH was used as an internal control. T: LSCC tissues; N: the adjacent normal tissues. c Statistical analysis reveals
an inverse correlation between relative miR-24 and XIAP mRNA expression level in LSCC tissues (n = 15; r =−0.508; P< 0.001). Corresponding P values
analyzed by Spearman correlation test are indicated. **P< 0.01 vs control
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whether miRNAs play a critical role in activation of XIAP
in LSCC requires further investigation, although luciferase
assays indicated that miR-24 binds to the 3′-UTR of XIAP
mRNA. In concordance with luciferase reporter results,
overexpression of miR-24 downregulates endogenous
XIAP protein levels in LSCC. Furthermore, LSCC XIAP
mRNA expression correlated with miR-24 expression, and
XIAP expression was elevated relative to that in a normal
human keratinocyte cell line. Furthermore, miR-24 ex-
pression in LSCC tissues was higher than that in adjacent
normal tissues, with XIAP expression inversely correlated
with miR-24 expression. More importantly, small interfer-
ing RNA (siRNA)-mediated XIAP knockdown mimics the
same effects of miR-24 upregulation on growth, apoptosis,
and radiosensitivity in LSCC. These results suggest that
XIAP mRNA may be a direct target of miR-24 in LSCC.
In conclusion, our study demonstrates that miR-24 is
downregulated in LSCC and re-expression of miR-24 in-
hibits growth, enhances apoptosis, and increases radiosen-
sitivity in LSCC. The data also demonstrate a functional
link between miR-24 and XIAP in LSCC, suggesting that
XIAP may be a target of miR-24, and that abnormal miR-
24 and XIAP expression may be correlated with aggressive
progression of LSCC. Several limits of our study should be
noted. First, other miR-24 target mRNAs need to be iden-
tified. Second, a larger scale study with appropriate tissue
samples is needed to investigate the clinicopathological
and prognostic significance of miR-24. Third, only one
tumor cell line was used in this study, so a larger number
of tumor cell lines could be included in the future in terms
of the fact that these cancers are heterogenous in nature.
Materials and methods
Tissue samples
Fifteen paired LSCC and adjacent normal tissues were col-
lected from the Department of Pathology in Jingling Hos-
pital between 2011 and 2013, after informed consent had
been obtained. The ethics committee of Jiangsu Province
Medical Association approved the study protocol. LSCC
diagnosis was determined according to the latest WHO
criteria and TNM stage classification (UICC 2002). None
of the patients had received chemotherapy or radiotherapy
before surgery. All tissue samples were snap-frozen in li-
quid nitrogen, and transferred to 500 ml TRIzol solution
(Invitrogen, Carlsbad, CA, USA) immediately after har-
vesting to avoid mRNA degradation. Samples were stored
in a biobank at −80 °C until processed.
Cell culture
Two LSCC cell lines (Hep-2 and AMC-HN-8) and a
normal human keratinocyte cell line (HaCaT) were
purchased from Shanghai Institute Chinese Academy of
Science (Shanghai, China), cultured in RPMI 1640media (Invitrogen) supplemented with 10 % fetal bovine
serum (FBS), and 100 μM each of penicillin and strepto-
mycin in a humidified atmosphere of 5 % CO2 at 37 °C.
Transfection of plasmids
For ectopic expression of miR-24 or knockdown of XIAP,
pGCMV/miR-24 (or pGCMV/miR-NC vector) or pSil/
shXIAP (pSil/shcontrol) were purchased from GenePharm
(Shanghai, China). Transfections were performed using
Lipofectamine™ 2000 (Invitrogen) according to the manu-
facturer’s instructions. Cells were transfected with recom-
binant DNA vectors containing a G418 selection marker
and selected on G418 (Sigma, St. Louis, MO, USA) at 600
mg/ml for 4 weeks. Single clones were maintained in
G418 at 100 mg/ml.
qRT-PCR assay
Total RNA was isolated using Trizol (Invitrogen), and
10 μg RNA used to synthesize cDNA with Super-Script
II First-Strand Synthesis System (Invitrogen), or Taq-
Man® MicroRNA Reverse Transcription Kit (Applied
Biosystems). Aliquots of the reaction mixture were used
for real-time PCR with Power SYBR Green PCR Master
Mix or with the TaqMan® 2 × Universal PCR Master
Mix. PCR reaction conditions: 50 °C for 20 s, 95 °C for
10 min followed by 40 cycles of 95 °C for 15 s, 60 °C for
1 min. We calculated a △Ct (target-reference), which is
equal to the difference between threshold cycles for
miR-24 (target) and the threshold cycle for U6 RNA
(reference) (△Ct (target-reference) = Ct target-Ct refer-
ence). The fold-change between patient or cell sample
and a normal control for miR-24 or XIAP was calculated
by the 2ˉΔΔCt method.
Western blotting assay
Cells were lysed using the mammalian protein extraction
reagent RIPA (Beyotime, Beijing, China) supplemented
with a protease inhibitor cocktail (Roche, Pleasanton, CA,
USA), and phenylmethylsulfonyl fluoride (PMSF) (Roche).
Approximately 50 μg protein extract was separated by
10 % SDS-PAGE, transferred to 0.22 μm nitrocellulose
(NC) (Sigma), and incubated with specific antibodies. Au-
toradiograms were quantified by densitometry using
Quantity One software (Bio-Rad, Brea, CA, USA). Rabbit
anti-XIAP, cleaved caspase-3, total caspase-3, cleaved
PARP, and total PARP were obtained from Cell Signaling
Technology (Danvers, MA, USA). GAPDH antibody was
used as a control.
Cell growth assay
Cell growth was measured by MTTassay (Sigma). In brief,
cells were seeded into five 96-well culture plates with each
plate having all three kinds of cells (6-parallel wells/
group). Each day, 200 μL MTT (5 mg/mL) was added to
Xu et al. Cancer Cell International  (2015) 15:61 Page 9 of 10each well, and the cells incubated at 37 °C for 4 h. Reac-
tions were stopped by lysing cells with 150 μL DMSO for
5 min. Optical density was determined on a Versamax mi-
croplate reader (Molecular Devices, Sunnyvale, CA, USA)
at 490 nm.
Colony formation assay
Cells were trypsinized to single cell suspensions and
seeded to 6-well plates at 600/well. After 14 days culture
in RPMI 1640 medium, colonies were stained with Giemsa
solution and the number of colonies counted. Each ex-
periment was performed in triplicate.
Flow cytometric detection of apoptosis
The cells were harvested, washed twice with cold PBS, fixed
in ice-cold 70 % ethanol, and incubated overnight at −20 °C.
Cells were then stained with 40 μg/mL of propidium iodide
(PI) for 30 min. A minimum of 1.0 × 106 cells were collected
and analyzed using Cell Quest software (Becton Dickinson
Co., Franklin Lakes, NJ, USA), and the percentage of cells
with apoptotic nuclei (% apoptosis) calculated.
Clonogenic survival assay
Cells were seeded into 6-well plates and cultured over-
night, radiated (0.0, 2.0, 4.0, 6.0 and 8.0 Gy), and cultured
for another 14 days. Colonies (>50 cells) were fixed with
chilled methanol and stained with crystal violet, and
counted on an inverted microscope. The surviving frac-
tion was calculated as follows: number of colonies/num-
ber of plated cells. All the procedures were repeated in
triplicate.
Dual-luciferase reporter assay
To validate XIAP as a direct target of miR-24, we per-
formed dual-luciferase reporter assays using a pLUC tar-
get reporter plasmid containing XIAP/3′-UTR (pLUC/
XIAP/3′-UTR-wt). Additionally, we generated a mutant
XIAP/3′-UTR reporter construct by site-directed muta-
genesis of the putative miR-24 target site in wild-type
XIAP/3′-UTR (pLUC/XIAP/3′-UTR-mut) using Strata-
gene QuikChange® Site-Directed Mutagenesis Kit (Strata-
gene, Heidelberg, Germany). Cells were transiently
cotransfected for 24 h with reporter plasmids (200 ng)
and pGCMV/miR-24 (or pGCMV/miR-NC) and har-
vested in reporter lysis buffer. Both firefly and Renilla
luciferase activities were measured using the Dual-
Luciferase assay kit (Promega, Madison, WI, USA)
according to the manufacturer’s instructions. Luciferase
activity was normalized against protein concentration and
expressed as a ratio of firefly to Renilla luciferase unit.
Statistical analysis
Statistical analysis was performed with SPSS version 13.0
(SPSS Inc., Chicago, IL, USA). Values are expressed as themean ± SD. χ2 test and t-test were applied as appropriate.
Correlations were evaluated by Spearman’s rank correl-
ation coefficients. A P < 0.05 was considered statistically
significant.
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